Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study.
Heo J, Kim YJ, Lee SW, Lee YJ, Yoon KT, Byun KS, Jung YJ, Tak WY, Jeong SH, Kwon KM, Suri V, Wu P, Jang BK, Lee BS, Cho JY, Jang JW, Yang SH, Paik SW, Kim HJ, Kwon JH, Park NH, Kim JH, Kim IH, Ahn SH, Lim YS.
Heo J, et al. Among authors: wu p.
Korean J Intern Med. 2023 Jul;38(4):504-513. doi: 10.3904/kjim.2022.252. Epub 2023 Jun 30.
Korean J Intern Med. 2023.
PMID: 37424500
Free PMC article.
Clinical Trial.